Mission Wealth Management, LP Amgen Inc Transaction History

Mission Wealth Management, LP

$4.24 Billion
Q4 2024

A detailed history of Mission Wealth Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Mission Wealth Management, LP holds 10,463 shares of AMGN stock, worth $3.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,463

Previous 12,359 15.34%

Holding current value

$3.1 Million

Previous $3.98 Million 31.52%

% of portfolio

0.06%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$258.78 - $328.31 $490,646 - $622,475	-1,896 Reduced 15.34%	10,463 $2.73 Million
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $152,524 - $166,328	493 Added 4.15%	12,359 $3.98 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $208,886 - $253,851	-795 Reduced 6.28%	11,866 $3.71 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $29,037 - $35,052	108 Added 0.86%	12,661 $3.6 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $261,325 - $294,806	1,022 Added 8.86%	12,553 $3.62 Million
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $86,148 - $106,955	-394 Reduced 3.3%	11,531 $3.1 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $31,711 - $37,498	-148 Reduced 1.23%	11,925 $2.65 Million
Q1 2023 Apr 07, 2023	BUY	$225.79 - $275.2 $67,059 - $81,734	297 Added 2.52%	12,073 $2.92 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $33,438 - $42,487	146 Added 1.26%	11,776 $3.09 Million
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $210,094 - $236,948	-936 Reduced 7.45%	11,630 $2.62 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $497,410 - $553,531	2,156 Added 20.71%	12,566 $3.06 Million
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $82,006 - $90,721	-374 Reduced 3.47%	10,410 $2.52 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $118,731 - $135,877	-597 Reduced 5.25%	10,784 $2.43 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $158,990 - $186,276	749 Added 7.04%	11,381 $2.42 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $49,986 - $55,455	214 Added 2.05%	10,632 $2.59 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $776,463 - $904,841	3,499 Added 50.57%	10,418 $2.59 Million
Q4 2020 Jan 19, 2021	SELL	$216.38 - $257.67 $160,986 - $191,706	-744 Reduced 9.71%	6,919 $1.59 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $180,211 - $200,409	768 Added 11.14%	7,663 $1.95 Million
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $21,165 - $25,973	107 Added 1.58%	6,895 $1.63 Million
Q1 2020 Apr 10, 2020	SELL	$182.24 - $241.7 $30,069 - $39,880	-165 Reduced 2.37%	6,788 $1.38 Million
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $51,465 - $66,150	272 Added 4.07%	6,953 $1.68 Million
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $22,286 - $26,703	128 Added 1.95%	6,681 $1.29 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $141,028 - $165,316	846 Added 14.82%	6,553 $1.21 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $508,787 - $573,514	-2,813 Reduced 33.02%	5,707 $1.08 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $26,581 - $31,029	-149 Reduced 1.72%	8,520 $1.66 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $32,611 - $36,764	176 Added 2.07%	8,669 $1.8 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $34,372 - $38,607	207 Added 2.5%	8,493 $1.57 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $13,046 - $15,246	-77 Reduced 0.92%	8,286 $1.41 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $80,850 - $90,334	479 Added 6.08%	8,363 $1.45 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $1.38 Million - $1.58 Million	-8,260 Reduced 51.16%	7,884 $1.47 Million
Q2 2017 Aug 11, 2017	BUY	N/A	16,144	16,144 $2.78 Million

Others Institutions Holding AMGN

# of Institutions

3,108

Shares Held

404M

Call Options Held

7.35M

Put Options Held

7.05M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.

Account

Mission Wealth Management, LP Amgen Inc Transaction History